Last Updated : December 18, 2008
Details
FilesGeneric Name:
Alendronate sodium / cholecalciferol
Project Status:
Complete
Therapeutic Area:
Osteoporosis
Manufacturer:
Merck Frosst Canda Ltd.
Brand Name:
Fosavance 70/5600
Project Line:
Reimbursement Review
Project Number:
SR0153-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Osteoporosis
Recommendation Type:
List in a similar manner to other drugs in class
Final Recommendation:
Files
Last Updated : December 18, 2008